Cencora Stock Today
| COR Stock | USD 350.32 4.32 1.25% |
PerformanceSolid
| Odds Of DistressLow
|
Cencora is selling at 350.32 as of the 15th of December 2025; that is 1.25% up since the beginning of the trading day. The stock's lowest day price was 344.01. Cencora has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Note, on September 1, 2021, Senator Thomas R Carper of US Senate acquired under $15k worth of Cencora's common stock.
Business Domain Health Care Equipment & Services | IPO Date 4th of April 1995 | Category Healthcare | Classification Health Care |
CoreSite Realty Corporation delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. Our scalable, flexible solutions and 460 dedicated employees consistently deliver unmatched data center options all of which leads to a best-in-class customer experience and lasting relationships. The company has 193.99 M outstanding shares of which 4.64 M shares are currently shorted by investors with about 2.9 days to cover. More on Cencora
Moving together with Cencora Stock
Moving against Cencora Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Cencora Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO, President | PharmD Mauch | ||||
| Old Names | [CONWERT IMMOBIL INV, CONWERT IMMOBIL INV - Dusseldorf Stock Exchang, Conwert Immobilien Invest SE, CONWERT IMMOBIL INV (COR.SG), Zortrax S.A.] | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, PSI 20 Stock, SP 500 Index, PSI All Share, Health Care, Health Care Providers & Services, REIT—Specialty, Real Estate (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsCencora can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cencora's financial leverage. It provides some insight into what part of Cencora's total assets is financed by creditors.
| |||||
Cencora (COR) is traded on New York Stock Exchange in USA and employs 47,000 people. Cencora is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 67.12 B. Cencora runs under Health Care Providers & Services sector within Health Care industry. The entity has 193.99 M outstanding shares of which 4.64 M shares are currently shorted by investors with about 2.9 days to cover.
Cencora has about 4.36 B in cash with 3.88 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Cencora Probability Of Bankruptcy
Ownership AllocationCencora holds a total of 193.99 Million outstanding shares. The majority of Cencora outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cencora to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cencora. Please pay attention to any change in the institutional holdings of Cencora as this could imply that something significant has changed or is about to change at the company. Also note that nearly one million six hundred eighty-seven thousand seven hundred fourty-three invesors are currently shorting Cencora expressing very little confidence in its future performance.
Check Cencora Ownership Details
Cencora Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Fmr Inc | 2025-06-30 | 3.1 M | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 3.1 M | |
| Capital Research Global Investors | 2025-06-30 | 2.6 M | |
| Norges Bank | 2025-06-30 | 2.3 M | |
| Northern Trust Corp | 2025-06-30 | 2.1 M | |
| Viking Global Investors Lp | 2025-06-30 | 2.1 M | |
| Bessemer Group Inc | 2025-06-30 | 2.1 M | |
| Citadel Advisors Llc | 2025-06-30 | 1.8 M | |
| Amundi | 2025-06-30 | 1.7 M | |
| Vanguard Group Inc | 2025-06-30 | 22.5 M | |
| Blackrock Inc | 2025-06-30 | 18.7 M |
Cencora Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cencora market risk premium is the additional return an investor will receive from holding Cencora long position in a well-diversified portfolio.
| Mean Deviation | 1.05 | |||
| Semi Deviation | 1.45 | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.17 |
Cencora Stock Against Markets
Cencora Corporate Directors
| David Wilson | Lead Independent Director | Profile | |
| James Attwood | Independent Director | Profile | |
| John Thompson | Independent Director | Profile | |
| Jean Bua | Independent Director | Profile |
Additional Tools for Cencora Stock Analysis
When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.